Innovation for people,
research for the future
ABOUT US
Nóos is an Italian company with over 20 years’ experience, which combines science and advanced technology to offer solutions and improve the health and well-being of individuals. Our passion for innovation leads us to research and develop new products that can enhance the quality of everyday life.
Scientific research, clinical studies, the necessary pharmaceutical rigour and a particular focus on family care are the unique qualities that allow us to achieve ever more ambitious goals, obtaining new patents and creating new formulas: this is the strength that makes us stand out from the crowd.
We regard science as a means of fulfilling the needs of families, both parents and children, and supporting current and future generations.
VISION
Nóos means innovation, research and quality.
The day-to-day wellbeing and future of individuals is at the heart of our corporate strategy.
MISSION
For over 20 years we have been designing, testing and developing high-quality food supplements and medical devices to meet the needs of families. Thanks to the enormous expertise gained by our founders through years in the pharmaceutical industry, we have successfully brought scientifically rigorous values and quality to our products.
OUR STORY
The company brings to its products, supplements and medical devices the same scientific approach and rigorous quality as that used in pharmaceuticals. Today, the medical community continues to recognise and appreciate these values, showing confidence and great interest in our therapeutic products, which are mainly geared to supporting paediatrics, neonatology, otolaryngology, gastroenterology, allergology and general practice.
The patented strain Limosilactobacillus reuteri LMG P-27481 was thus marketed for the first time in 2020 under the brand Reuterin® GG, today in the orosoluble drops and stick formulations, in association with L.rhamnosus GG.
Thanks to its ongoing commitment to research, in 2024 Nóos launches on the market, with the brands Reuterin LMG Bimbi drops and Reuterin LMG Difesa drops, two new formulations based exclusively on the patented strain Limosilactobacillus reuteri LMG P-27481, innovative products useful for promoting the balance of the intestinal bacterial flora and for supporting the immune system for children and adults.
